Analysis of the TEL protein during tumour angiogenesis

Anticancer Research

Volumn 19, Issue 4 B, 1999, Pages 2945-2951

  Edel, Michael J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Angiogenesis; Breast carcinoma; ETS; Human umbilical vein endothelial cell; TEL; Transcription factor

Indexed keywords

PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR ETS 2; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BASEMENT MEMBRANE; BREAST; BREAST CANCER; BREAST CARCINOMA; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OVARY; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; TUBE;

BREAST NEOPLASMS; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OVARY; PHENOTYPE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TYROSINE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033452560     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Corden-Carlo C: New insights into cancer provided by advances in molecular and cellular biology. In: Memorial Sloan-Kettering 1993:
2. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364, 1996.
3. Ferrara N, Henzel W: Pituitary follicular cells secrete a novel heparin-hinding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161: 851-858, 1984.
4. Brown LF, Berse B, Jackman RW, Tognazzi KAJG, Connolly JL, Schnitt SJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (Vascular Endothial Growth Factor) and its receptors in breast cancer. Hum Pathol 26(1): 86-91, 1995.
5. Toi M, Inada K, Suzuki H, Tominaga T: Tumour angiogenesis in breast cancer. Its importance as prognastic indicator and the association with vascular endothelial growth factor expression. Can Treat Res 36: 193-204, 1995.
6. Takahashi Y, Kitadai Y, Bucana C, Cleary K, Ellis L: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
7. Chen Z, Fisher R, Riggs C, Rhim J, Lautenberger J: Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res 57: 2013-2019, 1997.
8. Iwasaka C, Katsuhiro T, Mayumi A, Sato Y: Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 169: 522-531, 1996.
9. Wasylyk C, Wasylyk B: Oncogene conversion alters the transcriptional properties of ets. Cell Growth Differ 3: 617-625, 1992.
10. Vandenbunder B, Wernert N, Queva C, Desbiens X, Stehelin D: Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion? Folia Biol (Praha) 40: 301-313, 1994.
11. Wernert N, Raes M, Lassalle P, Dehouch M, Gosselin B, Vanderbunder B, Stehelin D: C-ets1 prolo-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140(1): 119-127, 1992.
12. Bolon I, Gouyer V, Devouassoux M, Vendenbynder B, Wernert N, Moro D, Brambilla C, Brambilla E: Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147(5): 1298-1310, 1995.
13. Ghysdael J, Boureux A: The ETS family of transcription regulators: oncogenes as transcriptional regulators. Oncogene 1: 29-89, 1997.
14. Maroulakou I, Papas T, Green J: Differential expression of ETS1 and ETS2 proto-oncogenes during murine emhryogenesis. Oncogene 9: 1551-1565, 1994.
15. Risau W, Flamme I: Vasculogenesis. Annu Rev Cell Biol 11: 73-91, 1995.
16. Watabe T, Yoshida K, Shindoh M, Kaya M, Fujikawa K, Sato H, Seiki M, Ishii S, Fujinaga K: The ets-1 and ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 77(1): 128-137, 1998.
17. Vandenbunder B, Queva C, Desbiens X, Wernert N, Stehelin D: Expression of the transcription factor c-ets1 correclates with the occurrence of invasive processes during normal and pathological development. Invasion Metastasis 14: 198-209, 1994.
18. Rabault B, and Ghysdael J: Calcium-induced phosphorylation of etsl inhibits its specific DNA bunding activity. J Biol Chem 269(45): 28143-28151, 1944.
19. Golub T, Barker F, Lovett M, Gilliland D: Fusion of PDGF receptor beta to a novel ets-like gene, TEL, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77: 307, 1994.
20. Poirel H, Oury C, Carron C, Duprez E, Laabi Y, Tsapis A, Romana S, Mauchauffe M, Le Conait M, Berger R, Ghysdael J, Bernard O: The TEL gene products: nuclear phosphoproteins with DNA binding properties. Oncogene 14: 349-357, 1997.
21. Poirel H, Laeronique V, Mauchauffe M, Leconait M, Raffoux E, Ganiel M, Erickson P, Drabkin H, Macloed R, Drexler H, Ghysdael J, Berger R, Bernard O: Analysis of TEL proteins in human leukemias. Oncogene 16(22): 2895-2903, 1998.
22. Wang L, Kuo F, Fujiwara Y, DG, Golub T, Orkin S: Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-relatcd factor TEL. EMBO J 16(14): 4374-4383, 1497.
23. Wernert N, Gilles F, Fafeur V, Bouali F, Raes M, Pyke C, Dupressoir T, Seitz O, Vandenhunder B, Stehelin D: Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. Cancer Res 54: 5683-5688, 1994.
24. Edel M: The ETS-related factor TEL is regulated by angiogenic growth factor VEGF in HUVE-Cells. Anticancer Res 18(6A): 4505-4510, 1998.
25. Jaffe E: Culture of human endothelial cells. Transplant Proc 12: 49-53, 1980.
26. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410, 1991.
27. Marias R, Wynne J, Triesman R: The SRF accessory protein EIk-1 contains a growth factor-regulated transcription activation domain. Cell 73: 381-393, 1993.
28. Pongubala JMR, Van Beveren C, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA, Atchinson ML: Effect of PU-I phosphorylation on interaction with NF-EM5 and transcription activation. Science 259: 1622-1625, 1993.
29. Rabault B, Ghysdael J: Calcium-induced phosphorylation of ETS-1 inhibits its specific DNA binding activity. J Biol Chem 269: 28143-28151, 1994.
30. Rabault B, Roussel MF, Tran Quang C, Ghysdael J: Phosphorylation of ETS-1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene 13: 877-881, 1996.
31. Yang B, Hauser C, Henkel G, Colman M, Van Berveran C, Stacey K, Hume D, Maki R, Ostrowski M: Ras-mediated phosphorylation of a conserved threonine residue enhances the transcriptional activities of c-ETS1 and C-ETS2. Mol Cell Biol 16: 538-547, 1996.
32. Augustin H, Braun K, Telemenakis I, Modlich U, Kuhn W: Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am J Pathol 147: 339-351, 1995.
33. Vandenbunder B, Pardanaud T, Jaffredo T, Mirabel M, Stehelin D: Complementary patterns of expression of c-ets1, c-myb and c-myc in the blood-forming system of the chick embryo. Development 106: 265-274, 1989.
34. Pardanaud L, Dieterlen-Lievre F: Expression of c-ets1 in early chick embryo mesoderm: relationship to the hemangioblastic lineage. Cell Adh Commun 1: 151-160, 1993.